These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29708923)

  • 41. Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation.
    Alonso R; Andres E; Mata N; Fuentes-Jiménez F; Badimón L; López-Miranda J; Padró T; Muñiz O; Díaz-Díaz JL; Mauri M; Ordovás JM; Mata P;
    J Am Coll Cardiol; 2014 May; 63(19):1982-9. PubMed ID: 24632281
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Familial hypercholesterolemia and lipoprotein(a) hyperlipidemia as independent and combined cardiovascular risk factors.
    Orsó E; Ahrens N; Kilalić D; Schmitz G
    Atheroscler Suppl; 2009 Dec; 10(5):74-8. PubMed ID: 20129380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Diagnosis and Treatment of Familial Hypercholesterolemia].
    Schöb M; Müller P; Gerth Y; Korte W; Rickli H; Brändle M; Bärlocher A; Bilz S
    Praxis (Bern 1994); 2018 Nov; 107(24):1345-1353. PubMed ID: 30482120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association Between Cholesterol Efflux Capacity and Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia.
    Ogura M; Hori M; Harada-Shiba M
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):181-8. PubMed ID: 26543100
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk.
    Agabiti Rosei E; Salvetti M
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):217-30. PubMed ID: 27567901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of lipid-lowering treatment in cardiovascular disease prevalence in familial hypercholesterolemia.
    Perez-Calahorra S; Laclaustra M; Marco-Benedí V; Lamiquiz-Moneo I; Pedro-Botet J; Plana N; Sanchez-Hernandez RM; Amor AJ; Almagro F; Fuentes F; Suarez-Tembra M; Civeira F;
    Atherosclerosis; 2019 May; 284():245-252. PubMed ID: 30827715
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SLC22A3 is associated with lipoprotein (a) concentration and cardiovascular disease in familial hypercholesterolemia.
    Paquette M; Bernard S; Baass A
    Clin Biochem; 2019 Apr; 66():44-48. PubMed ID: 30772277
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Lipoprotein(a) is associated to atherosclerosis in primary hypercholesterolemia].
    Bea AM; Mateo-Gallego R; Jarauta E; Villa-Pobo R; Calmarza P; Lamiquiz-Moneo I; Cenarro A; Civeira F
    Clin Investig Arterioscler; 2014; 26(4):176-83. PubMed ID: 24576773
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Value of the Definition of Severe Familial Hypercholesterolemia for Stratification of Heterozygous Patients.
    Pérez-Calahorra S; Sánchez-Hernández RM; Plana N; Marco-Benedi V; Pedro-Botet J; Almagro F; Brea A; Ascaso JF; Lahoz C; Civeira F;
    Am J Cardiol; 2017 Mar; 119(5):742-748. PubMed ID: 28081939
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers.
    Besseling J; Kindt I; Hof M; Kastelein JJ; Hutten BA; Hovingh GK
    Atherosclerosis; 2014 Mar; 233(1):219-23. PubMed ID: 24529147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population.
    Umans-Eckenhausen MA; Sijbrands EJ; Kastelein JJ; Defesche JC
    Circulation; 2002 Dec; 106(24):3031-6. PubMed ID: 12473547
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment].
    Češka R; Štulc T; Votavová L; Schwarzová L; Vaclová M; Freiberger T
    Vnitr Lek; 2016; 62(11):887-894. PubMed ID: 28128575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The very high cardiovascular risk in heterozygous familial hypercholesterolemia: Analysis of 734 French patients.
    Béliard S; Millier A; Carreau V; Carrié A; Moulin P; Fredenrich A; Farnier M; Luc G; Rosenbaum D; Toumi M; Bruckert E;
    J Clin Lipidol; 2016; 10(5):1129-1136.e3. PubMed ID: 27678429
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LRP1 gene polymorphisms are associated with premature risk of cardiovascular disease in patients with familial hypercholesterolemia.
    Aledo R; Alonso R; Mata P; Llorente-Cortés V; Padró T; Badimon L
    Rev Esp Cardiol (Engl Ed); 2012 Sep; 65(9):807-12. PubMed ID: 22819221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cascade screening for familial hypercholesterolemia: Practical consequences.
    Louter L; Defesche J; Roeters van Lennep J
    Atheroscler Suppl; 2017 Nov; 30():77-85. PubMed ID: 29096865
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
    Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapy.
    Galema-Boers AM; Lenzen MJ; Engelkes SR; Sijbrands EJ; Roeters van Lennep JE
    J Clin Lipidol; 2018; 12(2):409-416. PubMed ID: 29398430
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of familial hypercholesterolemia in patients from a general practice database.
    Casula M; Catapano AL; Rossi Bernardi L; Visconti M; Aronica A
    Atheroscler Suppl; 2017 Oct; 29():25-30. PubMed ID: 28965617
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical Features and Gaps in the Management of Probable Familial Hypercholesterolemia and Cardiovascular Disease.
    Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C
    Circ J; 2017 Dec; 82(1):218-223. PubMed ID: 28701632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.